Saba NF - Search Results

1

Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.

Chung CH, Li J, Steuer CE, Bhateja P, Johnson M, Masannat J, Poole MI, Song F, Hernandez-Prera JC, Molina H, Wenig BM, Kumar S, Kuperwasser C, Stephens PJ, Farinhas JM, Shin DM, Kish JA, Muzaffar J, Kirtane K, Rocco JW, Schell MJ, Saba NF, Bonomi M. Chung CH, et al. Among authors: saba nf. Clin Cancer Res. 2022 Jun 1;28(11):2329-2338. doi: 10.1158/1078-0432.CCR-21-3849. Clin Cancer Res. 2022. PMID: 35344035 Free PMC article. Clinical Trial.

2

Targeting the epidermal growth factor receptor. Trials in head and neck and lung cancer.

Saba NF, Khuri FR, Shin DM. Saba NF, et al. Oncology (Williston Park). 2006 Feb;20(2):153-61; discussion 162, 166, 169 passim. Oncology (Williston Park). 2006. PMID: 16562649 Review.

3

Moving toward bioadjuvant approaches to head and neck cancer prevention.

Saba NF, Hammond A, Shin DM, Khuri FR. Saba NF, et al. Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S132-5. doi: 10.1016/j.ijrobp.2007.05.041. Int J Radiat Oncol Biol Phys. 2007. PMID: 17848282 Review.

4

Targeting angiogenesis in head and neck cancer.

Saba NF, Shin DM, Khuri FR. Saba NF, et al. Curr Cancer Drug Targets. 2007 Nov;7(7):643-9. doi: 10.2174/156800907782418356. Curr Cancer Drug Targets. 2007. PMID: 18045069 Review.

5

Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.

Muller S, Su L, Tighiouart M, Saba N, Zhang H, Shin DM, Chen Z. Muller S, et al. Cancer. 2008 Jul 1;113(1):97-107. doi: 10.1002/cncr.23557. Cancer. 2008. PMID: 18473353 Free article.

6

Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug.

Saba NF, Wang X, Müller S, Tighiouart M, Cho K, Nie S, Chen Z, Shin DM. Saba NF, et al. Head Neck. 2009 Apr;31(4):475-81. doi: 10.1002/hed.21003. Head Neck. 2009. PMID: 19072997 Free PMC article.

7

Optimizing systemic therapy in squamous cell carcinoma of the head and neck with a focus on targeted agents.

Saba NF, Khuri FR. Saba NF, et al. Curr Opin Oncol. 2009 May;21(3):232-7. doi: 10.1097/cco.0b013e32832a56b3. Curr Opin Oncol. 2009. PMID: 19370807 Review.

8

Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: a retrospective single-institution analysis.

Saba NF, Edelman S, Tighiouart M, Gaultney J, Davis LW, Khuri FR, Chen A, Grist W, Shin DM. Saba NF, et al. Head Neck. 2009 Nov;31(11):1447-55. doi: 10.1002/hed.21120. Head Neck. 2009. PMID: 19431199

9

Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma.

Saba NF, Choi M, Muller S, Shin HJ, Tighiouart M, Papadimitrakopoulou VA, El-Naggar AK, Khuri FR, Chen ZG, Shin DM. Saba NF, et al. Cancer Prev Res (Phila). 2009 Sep;2(9):823-9. doi: 10.1158/1940-6207.CAPR-09-0077. Epub 2009 Sep 8. Cancer Prev Res (Phila). 2009. PMID: 19737986 Free PMC article.

10

Phase 1 and pharmacokinetic study of everolimus, a mammalian target of rapamycin inhibitor, in combination with docetaxel for recurrent/refractory nonsmall cell lung cancer.

Ramalingam SS, Harvey RD, Saba N, Owonikoko TK, Kauh J, Shin DM, Sun SY, Strychor S, Tighiouart M, Egorin MJ, Fu H, Khuri FR. Ramalingam SS, et al. Cancer. 2010 Aug 15;116(16):3903-9. doi: 10.1002/cncr.25264. Cancer. 2010. PMID: 20564143 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters